Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Proceeds to be utilized for general corporate purposes which may include the flexibility to invest in the growth of our oncology business and repayment of debtModerna has also purchased a hedge overlay intended to offset dilution up to a cap …